12 Innovations That Will Change Health Care and Medicine in the 2020s
Pocket-size ultrasound devices that cost 50 times less than the machines in hospitals (and connect to your phone). Virtual reality that speeds healing in rehab. Artificial intelligence that’s better than medical experts at spotting lung tumors. These are just some of the innovations now transforming medicine at a remarkable pace. No one can predict the future, but it can at least be glimpsed in the dozen inventions and concepts below. Like the people behind them, they stand at the vanguard of health care. Neither exhaustive nor exclusive, the list is, rather, representative of the recasting of public health and medical science likely to come in the 2020s. David Abney: Drone-delivered medical supplies Since March, UPS has been conducting a trial program called Flight Forward, using autonomous drone deliveries of critical medical samples including blood or tissue between two branches of a hospital in Raleigh, N.C., located 150 yards apart. A fleet-footed runner could cover the distance almost as fast as the drones, but as a proof-of-concept program, it succeeded, and in October the FAA granted the company approval to expand to 20 hospitals around the U.S. over the next two years. “We expect UPS Flight Forward to one day be a very significant part of our company,” says UPS CEO David Abney of the service, which will deliver urine, blood and tissue samples, and medical essentials like drugs and transfusable blood. UPS is not alone in pioneering air deliveries. ...
Publication date: Available online 2 August 2020Source: International Journal of Clinical and Health PsychologyAuthor(s): Marcin Rzeszutek, Amelia Zawadzka, Małgorzata Pięta, Angelika Houn, Daniel Pankowski, Beata Kręcisz
Publication date: Available online 1 August 2020Source: Pathology - Research and PracticeAuthor(s): Zong Wu, Wanqiu Li, Jiadong Li, Ying Zhang, Xinju Zhang, Yikun Xu, Yanping Hu, Qian Li, Qiangling Sun, Zhongliang Ma
Publication date: Available online 1 August 2020Source: Orthopaedics &Traumatology: Surgery &ResearchAuthor(s): Dhong Won Lee, Han Gil Jang, Young Jun Lee, Sung Gyu Moon, Na Ra Kim, Jin Goo Kim
Publication date: October 2020Source: Journal of Functional Foods, Volume 73Author(s): Miguel Z. Martín-González, Héctor Palacios-Jordan, Maria Ibars, Andrea Ardid-Ruiz, Albert Gibert-Ramos, Miguel A. Rodríguez, Manuel Suárez, Begoña Muguerza, Gerard Aragonès
Publication date: Available online 1 August 2020Source: Asian Nursing ResearchAuthor(s): Yu Liu, Tong-tong Jiang, Tie-ying Shi
Publication date: Available online 2 August 2020Source: Neurología (English Edition)Author(s): B. Alcón Durán, V. Hernández-Jiménez, M. Alcocer Ayuga, J. Saavedra Falero
Publication date: October 2020Source: Multiple Sclerosis and Related Disorders, Volume 45Author(s): Michelle H. Chen, Nancy D. Chiaravalloti, Helen M. Genova, Silvana L. Costa
This study used small RNA sequencing to identify miRNA biomarkers KD diagnosis based on a large sample size. Our findings shine a light on the understanding of molecular pathogenesis of KD and may improve the accuracy of KD diagnosis and prognosis in clinical. PMID: 32733962 [PubMed - in process]
This study evaluated the effects of different concentrations of AGEs on cell proliferation and migration. CCK8, transwell, and western blotting assays demonstrated that AGEs significantly increased cell proliferation and migration in a concentration-dependent manner and that the optimal proproliferative and promigratory concentrations of AGEs were 10 mg/L and 20 mg/L, respectively. AGE-induced cell proliferation, migration, and expression of filament actin (F-actin) were markedly attenuated by a PI3K inhibitor (LY2940002). Additionally, the phosphorylation of AKT was reduced when the receptor of advanced glyc...
In this study, the relationship between P2X7R activation and p38 phosphorylation in the dorsal root ganglion (DRG) and spinal dorsal horn (SDH) in the development and maintenance of BTZ-induced neuropathic pain was elucidated. The results showed that BTZ increased mechanical thresholds in rats, accompanied with upregulation of P2X7R expression and p38MAPK phosphorylation, indicating that P2X7R and p38MAPK are key molecules in the development and maintenance of BTZ-induced neuropathic pain. Inhibiting p38MAPK phosphorylation with SB203580 resulted in downregulation of P2X7R expression levels. Inhibition of P2X7R with Brilli...
More News: Accidents | African Health | Angioplasty | Back Pain | Baloon Angioplasty | Belgium Health | Biology | Biomedical Engineering | Biomedical Science | Brain | Brain Cancers | Cancer | Cancer & Oncology | Cardiac Catheterization | Cardiology | Cervical Cancer | Chronic Pain | Clinical Trials | Computers | CT Scan | Diabetes | Diabetes Type 1 | Diets | Economy | Endocrinology | Eyes | Gastroschisis Repair | Genetics | Ghana Health | Harvard | Health | Health Management | Heart | Heart Transplant | Hospitals | Immunotherapy | Insulin | Insurance | International Medicine & Public Health | Internet | Lung Cancer | Lung Transplant | Marketing | Multiple Sclerosis | National Institutes of Health (NIH) | Neurology | Neuroscience | Nicotine | Nigeria Health | Nutrition | Pain | Parkinson's Disease | PET Scan | Primary Care | Radiology | Rehabilitation | Research | Rural Health | Rwanda Health | Science | Sleep Disorders | Sleep Medicine | Stem Cell Therapy | Stem Cells | Stroke | Study | Substance Abuse | Ultrasound | Vertigo | Women | X-Ray | Yale